Creverse Inc
KOSDAQ:096240
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Creverse Inc
KOSDAQ:096240
|
KR |
|
Milestone Pharmaceuticals Inc
NASDAQ:MIST
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Creverse Inc's stock price target?
Not Available
Creverse Inc doesn't have any price targets made by Wall Street professionals.
What is Creverse Inc's Revenue forecast?
Projected CAGR
-4%
For the last 14 years the compound annual growth rate for Creverse Inc's revenue is 6%. The projected CAGR for the next 5 years is -4%.
What is Creverse Inc's Operating Income forecast?
Projected CAGR
53%
For the last 14 years the compound annual growth rate for Creverse Inc's operating income is -11%. The projected CAGR for the next 5 years is 53%.
What is Creverse Inc's Net Income forecast?
Projected CAGR
15%
For the last 14 years the compound annual growth rate for Creverse Inc's net income is -3%. The projected CAGR for the next 5 years is 15%.